{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:00:44Z","timestamp":1788926444050,"version":"build-2803163510"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Aging","award":["R01 AG063944"],"award-info":[{"award-number":["R01 AG063944"]}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["BO 934\/14-3"],"award-info":[{"award-number":["BO 934\/14-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["GA N\u00b0676536, QLK6-CT-2001-00360, RIICT-2006-062193, CIT5-CT-2005-028857, CIT4-CT-2006-028812, GA N\u00b0211909, GA N\u00b0227822, GA N\u00b0261982, GA N\u00b0283646, GA N\u00b0676536, GA N\u00b0870628, GA N\u00b0654221, GA N\u00b0823782"],"award-info":[{"award-number":["GA N\u00b0676536, QLK6-CT-2001-00360, RIICT-2006-062193, CIT5-CT-2005-028857, CIT4-CT-2006-028812, GA N\u00b0211909, GA N\u00b0227822, GA N\u00b0261982, GA N\u00b0283646, GA N\u00b0676536, GA N\u00b0870628, GA N\u00b0654221, GA N\u00b0823782"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020633","name":"Employment, Social Affairs and Inclusion","doi-asserted-by":"publisher","award":["VS 2015\/0195, VS 2016\/0135, VS 2018\/0285, VS 2019\/0332,VS 2020\/0313"],"award-info":[{"award-number":["VS 2015\/0195, VS 2016\/0135, VS 2018\/0285, VS 2019\/0332,VS 2020\/0313"]}],"id":[{"id":"10.13039\/100020633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) continues to go undiagnosed at significant rates in Europe, with few exploring the underlying mechanisms which prompt detection. Considering the causal link of numerous health conditions and CKD, this study investigates how individual and combined comorbidities are associated with the likelihood of CKD detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>In a large population study (n\u2009=\u200922,386) of older adults (50+) among 11 European countries and Israel, we calculate the prevalence of undiagnosed CKD using serum-equivalent cystatin C values, derived from dried blood spots. Logistic regressions are estimated to predict factors related to CKD diagnosis among the population and among those with diagnosed vs. undiagnosed CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Unawareness of CKD among older adults is estimated at 11% in the population and ~85% among CKD cases, with country heterogeneity. Common conditions which should prompt screening, such as hypertension and diabetes, do not increase the likelihood of CKD diagnosis among those with reported and measured CKD. Instead, conditions which are demanding in terms of pain and continuous care, such as cancer and arthritis, are associated with an increased likelihood of CKD detection. However, even in the case of four or more comorbidities, the likelihood of CKD detection is only 27.3%. Women and older individuals are more likely to remain undiagnosed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In order to increase the chance of detection, comorbidities need to be better interpreted as early warning signals of CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0333578","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:36:01Z","timestamp":1760463361000},"page":"e0333578","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["High unawareness of kidney dysfunction in European older adults and the importance of early detection through comorbidities"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5121-9684","authenticated-orcid":true,"given":"Hannah Marie","family":"Horton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"B\u00f6rsch-Supan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"5","key":"pone.0333578.ref001","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"KJ Jager","year":"2019","journal-title":"Kidney Int"},{"key":"pone.0333578.ref002","doi-asserted-by":"crossref","first-page":"100438","DOI":"10.1016\/j.lanepe.2022.100438","article-title":"Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2\u00b74 million patients from 11 countries: The CaReMe CKD study","volume":"20","author":"J Sundstr\u00f6m","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"pone.0333578.ref003","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00570-3","article-title":"An update on the global disparities in kidney disease burden and care across world countries and regions","volume":"12","author":"AK Bello","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"3","key":"pone.0333578.ref004","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(24)00050-0","article-title":"The major global burden of chronic kidney disease","volume":"12","author":"M Jadoul","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"7","key":"pone.0333578.ref005","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ckj\/sfab070","article-title":"Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney","volume":"14","author":"R Vanholder","year":"2021","journal-title":"Clin Kidney J"},{"issue":"9731","key":"pone.0333578.ref006","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Consortium Chronic Kidney Disease Prognosis","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"pone.0333578.ref007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038401","article-title":"Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"10","author":"MK Sullivan","year":"2020","journal-title":"BMJ Open"},{"key":"pone.0333578.ref008","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12882-015-0189-z","article-title":"The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study","volume":"16","author":"SDS Fraser","year":"2015","journal-title":"BMC Nephrol"},{"issue":"1","key":"pone.0333578.ref009","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12325-020-01568-8","article-title":"Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review","volume":"38","author":"M Murton","year":"2021","journal-title":"Adv Ther"},{"issue":"8","key":"pone.0333578.ref010","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s11255-023-03516-1","article-title":"Multimorbidity prevalence and patterns in chronic kidney disease: findings from an observational multicentre UK cohort study","volume":"55","author":"G Hawthorne","year":"2023","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"pone.0333578.ref011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.ki.5002273","article-title":"Chronic kidney disease management in the United Kingdom: NEOERICA project results","volume":"72","author":"PE Stevens","year":"2007","journal-title":"Kidney International"},{"issue":"10","key":"pone.0333578.ref012","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1681\/ASN.2013060604","article-title":"CKD and the risk of incident cancer","volume":"25","author":"WT Lowrance","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"pone.0333578.ref013","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","article-title":"The prevalence of anemia in patients with chronic kidney disease","volume":"20","author":"W McClellan","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"pone.0333578.ref014","article-title":"Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study","volume":"10","author":"H-Y Chiu","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"pone.0333578.ref015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/biom15060809","article-title":"The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention?","volume":"15","author":"S Biglari","year":"2025","journal-title":"Biomolecules"},{"key":"pone.0333578.ref016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ndt\/17.suppl_11.2","article-title":"The importance of early detection of chronic kidney disease","volume":"17","author":"F Locatelli","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"pone.0333578.ref017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067386","article-title":"Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study","volume":"13","author":"N Tangri","year":"2023","journal-title":"BMJ Open"},{"issue":"22","key":"pone.0333578.ref018","doi-asserted-by":"crossref","first-page":"11752","DOI":"10.3390\/ijerph182211752","article-title":"High Unawareness of Chronic Kidney Disease in Germany","volume":"18","author":"S Stolpe","year":"2021","journal-title":"IJERPH"},{"key":"pone.0333578.ref019","doi-asserted-by":"crossref","unstructured":"B\u00f6rsch-Supan M, Andersen-Ranberg K, Borbye-Lorenzen N. Munich Research Institute for the Economics of Aging and SHARE Analyses, Biomarkers in SHARE: Documentation of Implementation, Collection, and Analysis of Dried Blood Spot (DBS) Samples 2015-2023. 2024. https:\/\/www.mea-share.eu\/wp-content\/uploads\/2024\/05\/03-2024.pdf","DOI":"10.3386\/w32764"},{"issue":"4","key":"pone.0333578.ref020","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/ije\/dyt088","article-title":"Data Resource Profile: the Survey of Health, Ageing and Retirement in Europe (SHARE)","volume":"42","author":"A B\u00f6rsch-Supan","year":"2013","journal-title":"Int J Epidemiol"},{"key":"pone.0333578.ref021","article-title":"Survey of Health, Ageing and Retirement in Europe (SHARE) Wave 6 2022","author":"A B\u00f6rsch-Supan","journal-title":"SHARE-ERIC"},{"key":"pone.0333578.ref022","author":"P Vogl","year":"2014"},{"issue":"4","key":"pone.0333578.ref023","doi-asserted-by":"crossref","DOI":"10.1002\/ajhb.23517","article-title":"Dried blood spot collection, sample quality, and fieldwork conditions: Structural validations for conversion into standard values","volume":"33","author":"A B\u00f6rsch-Supan","year":"2021","journal-title":"Am J Hum Biol"},{"issue":"8","key":"pone.0333578.ref024","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jama.2024.0172","article-title":"Including Cystatin C Levels May Be Better for Diagnosing CKD","volume":"331","author":"E Harris","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"pone.0333578.ref025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"LA Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0333578.ref026","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/MNH.0b013e328326f3dd","article-title":"Association of cystatin C with adverse outcomes","volume":"18","author":"M Madero","year":"2009","journal-title":"Current Opinion in Nephrology and Hypertension"},{"issue":"11","key":"pone.0333578.ref027","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1373\/clinchem.2009.128397","article-title":"Cystatin C and Cardiovascular Risk","volume":"55","author":"N Taglieri","year":"2009","journal-title":"Clinical Chemistry"},{"issue":"3","key":"pone.0333578.ref028","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7326\/M23-1138","article-title":"Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C","volume":"177","author":"EL Fu","year":"2024","journal-title":"Ann Intern Med"},{"key":"pone.0333578.ref029","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/geroni\/igaa057.1661","article-title":"Cystatin C Trajectories Among Middle-Aged and Older Americans","volume":"4","author":"E Zhao","year":"2020","journal-title":"Innovation in Aging"},{"key":"pone.0333578.ref030","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Group Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work","year":"2024","journal-title":"Kidney Int"},{"key":"pone.0333578.ref031","unstructured":"De Luca G, Rossetti C. Stata program to compute calibrated weights from scientific use file and additional database. 2018."},{"issue":"6","key":"pone.0333578.ref032","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/qjmed\/hcq045","article-title":"Renal function, cardiovascular disease risk factors\u2019 prevalence and 5-year disease incidence; the role of diet, exercise, lipids and inflammation markers: the ATTICA study","volume":"103","author":"C Chrysohoou","year":"2010","journal-title":"QJM"},{"issue":"5","key":"pone.0333578.ref033","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae117","article-title":"Prevalence of chronic kidney disease in France: methodological considerations and pitfalls with the use of Health claims databases","volume":"17","author":"C Couchoud","year":"2024","journal-title":"Clin Kidney J"},{"issue":"7","key":"pone.0333578.ref034","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"A Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"pone.0333578.ref035","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2337\/dc21-0723","article-title":"Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database","volume":"44","author":"D Alfego","year":"2021","journal-title":"Diabetes Care"},{"issue":"12","key":"pone.0333578.ref036","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/ndt\/gfw354","article-title":"Prevalence and recognition of chronic kidney disease in Stockholm healthcare","volume":"31","author":"A Gasparini","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0333578.ref037","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ckj\/sfab210","article-title":"Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care","volume":"15","author":"A Bosi","year":"2021","journal-title":"Clin Kidney J"},{"issue":"1718","key":"pone.0333578.ref038","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2016.14313","article-title":"Prevalence and determinants of chronic kidney disease in the Swiss population","volume":"146","author":"V Forni Ogna","year":"2016","journal-title":"Swiss Med Wkly"},{"issue":"4","key":"pone.0333578.ref039","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-074064","article-title":"Are there lost opportunities in chronic kidney disease? A region-wide cohort study","volume":"14","author":"J Sundstr\u00f6m","year":"2024","journal-title":"BMJ Open"},{"issue":"7","key":"pone.0333578.ref040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069313","article-title":"Characteristics, management and outcomes in patients with CKD in a healthcare region in Sweden: a population-based, observational study","volume":"13","author":"B Agvall","year":"2023","journal-title":"BMJ Open"},{"key":"pone.0333578.ref041","unstructured":"AstraZeneca Switzerland. Chronic kidney disease in Switzerland \u2013 fact sheet. https:\/\/www.astrazeneca.ch\/content\/dam\/az-ch\/Media\/Press_release\/2024\/EN_250313_Faktenblatt_Chronische%20Nierenkrankheit%20in%20der%20Schweiz.pdf. 2025 July 28."},{"issue":"4","key":"pone.0333578.ref042","first-page":"302","article-title":"A Summary of Worldwide National Activities in Chronic Kidney Disease (CKD) Testing","volume":"28","author":"R Ruiz-Arenas","year":"2017","journal-title":"EJIFCC"},{"issue":"8","key":"pone.0333578.ref043","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s40620-022-01353-6","article-title":"\u201cThe Disease Awareness Innovation Network\u201d for chronic kidney disease identification in general practice","volume":"35","author":"F Pesce","year":"2022","journal-title":"J Nephrol"},{"issue":"5","key":"pone.0333578.ref044","first-page":"263","article-title":"Prevalence of chronic kidney disease based on Estonian e-health data","volume":"102","author":"M Rosenberg","year":"2023","journal-title":"Eesti Arst"},{"issue":"10","key":"pone.0333578.ref045","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1111\/dom.15789","article-title":"Barriers to early diagnosis of chronic kidney disease and use of sodium-glucose cotransporter-2 inhibitors for renal protection: A comprehensive review and call to action","volume":"26","author":"L Czupryniak","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"pone.0333578.ref046","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2022.w30197","article-title":"Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology","volume":"152","author":"E Christ","year":"2022","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"pone.0333578.ref047","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/cclm-2023-0987","article-title":"Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: insights from the 2022 EFLM Task Group on CKD survey","volume":"62","author":"E Cavalier","year":"2023","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"pone.0333578.ref048","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ckj\/sfv111","article-title":"The global nephrology workforce: emerging threats and potential solutions!","volume":"9","author":"MU Sharif","year":"2015","journal-title":"Clin Kidney J"},{"issue":"2","key":"pone.0333578.ref049","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae393","article-title":"The management of chronic kidney disease in primary care in Denmark: patient characteristics, treatment, follow-up, progression and referral","volume":"18","author":"H Birn","year":"2024","journal-title":"Clinical Kidney Journal"},{"issue":"10","key":"pone.0333578.ref050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017902","article-title":"International variations in primary care physician consultation time: a systematic review of 67 countries","volume":"7","author":"G Irving","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0333578.ref051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ckj\/sfaa217","article-title":"European East\u2013West divide in kidney disease: the need to understand the drivers of chronic kidney disease outcomes","volume":"14","author":"S Carriazo","year":"2020","journal-title":"Clinical Kidney Journal"},{"issue":"7","key":"pone.0333578.ref052","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.2015050542","article-title":"CKD Prevalence Varies across the European General Population","volume":"27","author":"K Br\u00fcck","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"pone.0333578.ref053","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000507774","article-title":"Chronic Kidney Disease Awareness and Longitudinal Health Outcomes: Results from the REasons for Geographic And Racial Differences in Stroke Study","volume":"51","author":"SL Tummalapalli","year":"2020","journal-title":"Am J Nephrol"},{"issue":"20","key":"pone.0333578.ref054","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/archinte.168.20.2268","article-title":"Patient awareness of chronic kidney disease: trends and predictors","volume":"168","author":"LC Plantinga","year":"2008","journal-title":"Arch Intern Med"},{"key":"pone.0333578.ref055","unstructured":"European Kidney Patient\u2019s Foundation. The realities of living with CKD: People with T2D and CKD speak up. 2023. https:\/\/ekpf.eu\/wp-content\/uploads\/2023\/03\/EKPF-Designed-Patient-Insights-Report_FINAL-1.pdf"},{"issue":"1","key":"pone.0333578.ref056","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11255-019-02346-4","article-title":"Patients with rheumatoid arthritis have an increased risk of incident chronic kidney disease: a systematic review and meta-analysis of cohort studies","volume":"52","author":"S Raksasuk","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"pone.0333578.ref057","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1053\/j.ajkd.2007.11.023","article-title":"Socioeconomic status and the incidence of ESRD","volume":"51","author":"MM Ward","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"pone.0333578.ref058","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.amjmed.2011.11.026","article-title":"Awareness of Kidney Disease and Relationship to End-stage Renal Disease and Mortality","volume":"125","author":"A Whaley-Connell","year":"2012","journal-title":"The American Journal of Medicine"},{"key":"pone.0333578.ref059","unstructured":"Centers for Disease Control and Prevention. CDC Surveillance System: Trends in Prevalence of CKD Stages among U.S. Adults. https:\/\/nccd.cdc.gov\/CKD\/detail.aspx?Qnum=Q372.2024 August 12."},{"issue":"5","key":"pone.0333578.ref060","first-page":"901","article-title":"Inconsistency in the Self-report of Chronic Diseases in Panel Surveys: Developing an Adjudication Method for the Health and Retirement Study","volume":"73","author":"CT Cigolle","year":"2018","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"pone.0333578.ref061","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.annepidem.2023.09.009","article-title":"Are self-reported medical conditions and medicine use from middle-aged and older adults credible? A validation study comparing Danish SHARE-data with National Health Register data","volume":"87","author":"J Mose","year":"2023","journal-title":"Ann Epidemiol"},{"issue":"2","key":"pone.0333578.ref062","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2215\/CJN.04381007","article-title":"Screening for chronic kidney disease: where does Europe go?","volume":"3","author":"PE de Jong","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:36:11Z","timestamp":1760463371000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333578"}},"subtitle":[],"editor":[{"given":"Ahmet","family":"Murt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":62,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0333578","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]}}}